Is there a threat that increased and longer satiety, which is advantageous in case of BED treatment or proper weight-loss therapy, may provoke restrictive eating behaviors in some patients, especially those who take GLP-1 ARs without actual medical supervision? The gene discussed is GLP1R; the disease is X-linked cone dysfunction syndrome with myopia.